Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$703M |
| 2 |
Tesla
TSLA
|
+$585M |
| 3 |
JPMorgan Chase
JPM
|
+$582M |
| 4 |
Amazon
AMZN
|
+$566M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$349M |
| 2 |
Home Depot
HD
|
+$334M |
| 3 |
T-Mobile US
TMUS
|
+$270M |
| 4 |
Cigna
CI
|
+$258M |
| 5 |
CDW
CDW
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.12% |
| 2 | Healthcare | 2.55% |
| 3 | Financials | 2.39% |
| 4 | Consumer Discretionary | 2.14% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7226
Vanda Pharmaceuticals
VNDA
$323M
| $867K | ﹤0.01% |
87,735
+52,058
| +146% | +$550K |
|
7227
Vanguard Morningstar Large-Cap ETF
VV
$54.2B
| $867K | ﹤0.01% |
5,300
-2,007
| -27% | -$365K |
|
7228
PUT
ProShares UltraShort Dow 30
DXD
$43.4M
| $866K | ﹤0.01% |
14,740
+4,220
| +40% | +$206K |
|
7229
Teucrium Agricultural Fund
TAGS
$20.2M
| $866K | ﹤0.01% |
+27,845
| New | +$842K |
|
7230
Telesat
TSAT
$727M
| $866K | ﹤0.01% |
110,881
-64,938
| -37% | -$718K |
|
7231
PUT
Atomera
ATOM
$196M
| $865K | ﹤0.01% |
85,400
+22,200
| +35% | +$263K |
|
7232
PUT
Invesco China Technology ETF
CQQQ
$3.15B
| $865K | ﹤0.01% |
23,800
+5,200
| +28% | +$231K |
|
7233
Invesco S&P 500 Momentum ETF
SPMO
$22.1B
| $865K | ﹤0.01% |
17,203
+13,074
| +317% | +$708K |
|
7234
KVH Industries
KVHI
$141M
| $864K | ﹤0.01% |
93,630
+25,555
| +38% | +$231K |
|
7235
Cerus
CERS
$570M
| $863K | ﹤0.01% |
239,610
+108,226
| +82% | +$518K |
|
7236
Timothy Plan US Large/Mid Cap Core ETF
TPLC
$316M
| $863K | ﹤0.01% |
+28,630
| New | +$949K |
|
|
VINC
7237
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $863K | ﹤0.01% |
31,278
+82
| +0.3% | +$2.36K |
|
|
KLDW
7238
DELISTED
Knowledge Leaders Developed World ETF
KLDW
| $863K | ﹤0.01% |
26,205
-11,168
| -30% | -$406K |
|
7239
PUT
Amplitude
AMPL
$1.58B
| $862K | ﹤0.01% |
55,700
-53,600
| -49% | -$859K |
|
7240
Occidental Petroleum Corp Warrants
OXY.WS
$35.3B
| $862K | ﹤0.01% |
21,748
-14
| -0.1% | -$590 |
|
|
BHVN
7241
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $862K | ﹤0.01% |
5,700
-15,200
| -73% | -$2.25M |
|
7242
VictoryShares US Small Cap High Div Volatility Wtd ETF
CSB
$265M
| $861K | ﹤0.01% |
18,579
-13,302
| -42% | -$707K |
|
7243
CALL
Capricor Therapeutics
CAPR
$410M
| $860K | ﹤0.01% |
143,300
+85,500
| +148% | +$437K |
|
7244
ProShares UltraShort SmallCap600
SDD
$1.31M
| $860K | ﹤0.01% |
27,063
+16,471
| +156% | +$436K |
|
|
ABST
7245
DELISTED
Absolute Software Corp
ABST
| $860K | ﹤0.01% |
74,015
+36,983
| +100% | +$377K |
|
7246
PUT
Ichor Holdings
ICHR
$2.45B
| $859K | ﹤0.01% |
35,500
+15,500
| +78% | +$458K |
|
7247
CALL
ING
ING
$101B
| $859K | ﹤0.01% |
101,000
+63,700
| +171% | +$591K |
|
|
CMBT
7248
CALL
CMB.TECH NV
CMBT
$5.07B
| $859K | ﹤0.01% |
55,800
-76,700
| -58% | -$1.17M |
|
7249
PUT
Insperity
NSP
$1.99B
| $858K | ﹤0.01% |
8,400
-7,200
| -46% | -$773K |
|
7250
ProShares Ultra S&P500
SSO
$8.38B
| $858K | ﹤0.01% |
43,202
-295,190
| -87% | -$7.3M |
|
Similar funds
Ken Griffin's Q3 2022 Portfolio in Review
As of Q3 2022, Ken Griffin held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Ken Griffin deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.
By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.
- Ken Griffin's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
- Ken Griffin added most to Apple in Q3 2022, an estimated $703M increase.
- Ken Griffin's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
- Ken Griffin fully exited Regions Financial in Q3 2022, selling an estimated $207M.
- Ken Griffin's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
- Ken Griffin opened 1,622 new positions and closed 1,858 in Q3 2022.
- Ken Griffin's portfolio value rose 13% quarter-over-quarter to $439B.
Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.